SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt
NCT06588179
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
58
Enrollment
OTHER
Sponsor class
Conditions
NMIBC
Interventions
DRUG:
SHR-1501+SHR-2005
Sponsor
Fudan University